RxDoctor Payments Data

Rebecca Chung, OD

Optometrist · Salem, ORNPI 1467948554

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $3,180 of the $5,281 with a category attached, or 60.2%. 11 manufacturers reported payments, led by Bausch & Lomb, A Division Of Bausch Health US, LLC at 27.1% of the total. Reporting peaked in 2019 at $3,676 and has fallen 67.2% since, to $1,206 in 2024. Among optometrist clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,281in general payments, 2019–2025

Across 51 payments — averaging $103.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb, A Division Of Bausch Health US, LLC$1K
  • Johnson & Johnson Vision Care, Inc.$1K
  • Coopervision Inc.$1K
  • Valley Contax, Inc.$810
  • Tarsus Pharmaceuticals, Inc.$125
  • Kala Pharmaceuticals, Inc.$120
  • plus $183 from 5 others

What the payments were for

  • Consulting fees$1002%
  • Speaking & faculty fees$501%
  • Travel & lodging$3,18060%
  • Food & beverage$1,88336%
  • Gifts$681%

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,281 in reported general payments places this provider in the 90th percentile of 684 optometrist providers in Oregon.

See all optometrist providers in Oregon

Medicare billing

Part B allowed, 2024
$53,386
Medicare patients
359
Services billed
555

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine55$38,523
Cyclosporine14$5,067
Latanoprost315$3,667
Tobramycin-DexamethasoneTobramycin/Dexamethasone12$454
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat23$320
Doxycycline Hyclate12$304
Timolol Maleate44$299
Brimonidine Tartrate51$171

Paid to pharmacies, not to this prescriber.

Other optometrist in Salem

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →